Discovering the next generation of precision cancer medicines
Tango Therapeutics is a clinical-stage biotechnology company leveraging the principle of synthetic lethality to discover novel drug targets and develop precision cancer medicines. The company's integrated discovery platform uncovers vulnerabilities arising from tumor suppressor gene loss in specific cancer types, enabling targeted therapies for genetically defined patient populations with limited treatment options.
Tech & App Stack is available on paid plans
Upgrade to Silver or higher to reveal the full technology and app stack for any company.
View pricingCreate a free account to see funding visualizations and detailed round data.
Create Free AccountOct 2025
May 2025
Aug 2021
Apr 2020
Oct 2017
Create a free account to see which investors have funded this company.
Create Free Account
Late-stage biopharma using single-molecule tracking, AI, and engineering to discover and develop ...
Asymchem provides R&D and one-stop production services to the world's top pharmaceutical companies.
South Korean biotech company and global leader in medical aesthetics, manufacturing botulinum tox...
Global full-service clinical research organization (CRO) and scientific advisory partner for biot...
Health insurance company using technology to make health care simple, affordable, and accessible.
Global clinical research organization specializing in early-stage clinical trials and bioanalytic...
